brusatol has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, WCS; Huang, QH; Huang, Y; Lin, ZX; Xian, YF; Yang, W; Zhang, J; Zuo, Z | 1 |
| Bai, Y; Gao, J; Hou, J; Wang, J; Zhou, J | 1 |
2 other study(ies) available for brusatol and Neoplasm Metastasis
| Article | Year |
|---|---|
Brusatol suppresses the tumor growth and metastasis of colorectal cancer via upregulating ARRDC4 expression through modulating PI3K/YAP1/TAZ Pathway.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Signal Transduction | 2023 |
Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Laryngeal Neoplasms; Male; Mice, Inbred BALB C; Neoplasm Metastasis; Phosphorylation; Quassins; RNA, Messenger; S Phase; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |